Durable Response to Osimertinib in a Chinese Patient with Metastatic Lung Adenocarcinoma Harboring a Rare EGFR L858R/D761Y Compound Mutation

Uncommon mutations account for 10–15% of epidermal growth factor receptor (EGFR) mutations in patients with non-small-cell lung cancer (NSCLC). However, in spite of the wealth of knowledge of the clinical significance and tyrosine kinase inhibitor (TKI) sensitivity of these mutations, acquisition of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yajie, Tang, Jianning, Li, Xin, Qin, Tian, Wei, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569175/
https://www.ncbi.nlm.nih.gov/pubmed/33116624
http://dx.doi.org/10.2147/OTT.S268593

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7569175/
https://www.ncbi.nlm.nih.gov/pubmed/33116624
http://dx.doi.org/10.2147/OTT.S268593

Ejemplares similares